The SYT-SSX Fusion Protein Down-Regulates the Cell Proliferation Regulator COM1 in t(x;18) Synovial Sarcoma

REFERENCES

• Bedner, E., P. Smolewski, P. Amstad, and Z. Darzynkiewicz. 2000. Activation of caspases measured in situ by binding of fluorochrome-labeled inhibitors of caspases (FLICA): correlation with DNA fragmentation. Exp. Cell Res. 259:308–313.
   PubMed Web of Science ®Google Scholar
• Bratland, A., K. Risberg, G. M. Maelandsmo, K. B. Gutzkow, O. E. Olsen, A. Moghaddam, M. Y. Wang, C. M. Hansen, H. K. Blomhoff, J. P. Berg, O. Fodstad, and A. H. Ree. 2000. Expression of a novel factor, com1, is regulated by 1,25-dihydroxyvitamin D3 in breast cancer cells. Cancer Res. 60:5578–5583.
   PubMedGoogle Scholar
• Brett, D., S. Whitehouse, P. Antonson, J. Shipley, C. Cooper, and G. Goodwin. 1997. The SYT protein involved in the t(X;18) synovail sarcoma translocation is a transcriptional activator localised in nuclear bodies. Hum. Mol. Genet. 6:1559–1564.
   PubMed Web of Science ®Google Scholar
• Carracedo, A., M. Lorente, A. Egia, C. Blazquez, S. Garcia, V. Giroux, C. Malicet, R. Villuendas, M. Gironella, L. Gonzalez-Feria, M. A. Piris, J. L. Iovanna, M. Guzman, and G. Velasco. 2006. The stress-regulated protein p8 mediates cannabinoid-induced apoptosis of tumor cells. Cancer Cell 4:301–312.
   Google Scholar
• Clark, J., P. J. Rocques, A. J. Crew, S. Gill, J. Shipley, A. M. Chan, B. A. Gusterson, and C. S. Cooper. 1994. Identification of novel genes, SYT and SSX, in the t(X;19)(p11.2;q11.2) translocation found in human synovial sarcoma. Nat. Genet. 7:502–508.
   PubMed Web of Science ®Google Scholar
• Crew, A. J., J. Clark, C. Fisher, S. Gill, R. Grimer, A. Chand, J. Shipley, B. A. Gusterson, and C. S. Cooper. 1995. Fusion of SYT to two genes, SSX1 and SSX2, encoding proteins with homology to the Kuppel-associated box in human synovial sarcoma. EMBO J. 14:2333–2340.
   PubMed Web of Science ®Google Scholar
• de Bruijn, D. R., N. R. dos Santos, J. Thijssen, M. Balemans, S. Debernardi, B. Linder, B. D. Young, and A. G. van Kessel. 2001. The synovial sarcoma associated protein SYT interacts with the acute leukemia associated protein AF10. Oncogene 20:3281–3289.
   PubMedGoogle Scholar
• de Leeuw, B., M. Balemans, D. Olde Weghuis, and A. G. van Kessel. 1995. Identification of two alternative fusion genes, SYT-SSX1 and SYT-SSX2, in t(X;18)(p11.2;q11.2)-positive synovial sarcomas. Hum. Mol. Genet. 4:1097–1099.
   PubMed Web of Science ®Google Scholar
• dos Santos, N. R., D. R. de Bruijn, and A. G. van Kessel. 2001. Molecular mechanisms underlying human synovial sarcoma development. Genes Chromosomes Cancer 30:1–14.
   PubMed Web of Science ®Google Scholar
• Eid, J. E., A. L. Kung, R. Scully, and D. M. Livingston. 2000. p300 Interacts with the nuclear proto-oncoprotein SYT as part of the active control of cell adhesion. Cell 102:839–848.
   PubMed Web of Science ®Google Scholar
• Gure, A. O., O. Tureci, U. Sahin, S. Tsang, M. J. Scanlan, E. Jager, A. Knuth, M. Pfreundschuh, L. J. Old, and Y. T. Chen. 1997. SSX: a multigene family with several members transcribed in normal testis and human cancer. Int. J. Cancer 72:965–971.
   PubMed Web of Science ®Google Scholar
• Gure, A. O., I. J. Wei, L. J. Old, and Y. T. Chen. 2002. The SSX gene family: characterization of 9 complete genes. Int. J. Cancer 101:448–453.
   PubMed Web of Science ®Google Scholar
• Ishida, M., S. Tanaka, M. Ohki, and T. Ohta. 2004. Transcriptional co-activator activity of SYT is negatively regulated by BRM and Brg1. Genes Cells 9:419–428.
   PubMedGoogle Scholar
• Ito, T., M. Ouchida, S. Ito, Y. Jitsumori, Y. Morimoto, T. Ozaki, A. Kawai, H. Inoue, and K. Shimizu. 2004. SYT, a partner of SYT-SSX oncoprotein in synovial sarcomas, interacts with mSin3A, a component of histone deacetylase complex. Lab. Investig. 84:1484–1490.
   PubMed Web of Science ®Google Scholar
• Ito, Y., H. Yoshida, Y. Motoo, E. Miyoshi, J. L. Iovanna, C. Tomoda, T. Uruno, Y. Takamura, A. Miya, K. Kobayashi, F. Matsuzuka, N. Matsuura, K. Kuma, and A. Miyauchi. 2003. Expression and cellular localization of p8 protein in thyroid neoplasms. Cancer Lett. 201:237–244.
   PubMedGoogle Scholar
• Ladanyi, M., C. R. Antonescu, D. H. Leung, J. M. Woodruff, A. Kawai, J. H. Healey, M. F. Brennan, J. A. Bridge, J. R. Neff, F. G. Barr, J. D. Goldsmith, J. S. Brooks, J. R. Goldblum, S. Z. Ali, J. Shipley, C. S. Cooper, C. Fisher, B. Skytting, and O. Larsson. 2002. Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients. Cancer Res. 62:135–140.
   PubMed Web of Science ®Google Scholar
• Lim, F. L., M. Soulez, D. Koczan, H. J. Thiesen, and J. C. Knight. 1998. A KRAB-related domain and a novel transcription repression domain in protein encoded by SSX genes that are disrupted in human sarcomas. Oncogene 17:2013–2018.
   PubMedGoogle Scholar
• Malicet, C., N. Lesavre, S. Vasseur, and J. L. Iovanna. 2003. p8 inhibits the growth of human pancreatic cancer cells and its expression is induced through pathways involved in growth inhibition and repressed by factors promoting cell growth. Mol. Cancer 2:37–48.
   PubMedGoogle Scholar
• Nagai, M., S. Tanaka, M. Tsuda, S. Endo, H. Kato, H. Sonobe, A. Minami, H. Hiraga, H. Nishihara, H. Sawa, and K. Nagashima. 2001. Analysis of transforming activity of human synovial sarcoma-associated chimeric protein SYT-SSX1 bound to chromatin remodeling factor hBRM/hSNF1αlpha. Proc. Natl. Acad. Sci. USA 98:3843–3848.
   PubMed Web of Science ®Google Scholar
• Papathanasiou, M. A., N. C. Kerr, J. H. Robbins, O. W. McBride, I. Alamo, Jr., S. F. Barrett, I. D. Hickson, and A. J. Fornace, Jr. 1991. Induction by ionizing radiation of the gadd45 gene in cultured human cells: lack of mediation by protein kinase C. Mol. Cell. Biol. 11:1009–1016.
   PubMed Web of Science ®Google Scholar
• Perani, M., C. J. Ingram, C. S. Cooper, M. D. Garrett, and G. H. Goodwin. 2003. Conserved SNH domain of the proto-oncoprotein SYT interacts with components of the human chromatin remodelling complexes, while the QPGY repeat domain forms homo-oligomers. Oncogene 22:8156–8167.
   PubMedGoogle Scholar
• Ree, A. H., M. Tvermyr, O. Engebraaten, M. Rooman, O. Rosok, E. Hovig, L. A. Meza-Zepeda, O. S. Bruland, and O. Fodstad. 1999. Expression of a novel factor in human breast cancer cells with metastatic potential. Cancer Res. 59:4675–4680.
   PubMedGoogle Scholar
• Skytting, B., G. Nilsson, B. Brodin, Y. Xie, J. Lundeberg, M. Uhlen, and O. Larsson. 1999. A novel fusion gene, SYT-SSX4, in synovial sarcoma. J. Natl. Cancer Inst. 91:974–975.
   PubMedGoogle Scholar
• Soulier, J., A. Madani, V. Cacheux, M. Rosenzwajg, F. Sigaux, and M. H. Stern. 1994. The MTCP-1/c6.1B gene encodes for a cytoplasmic 8 kD protein overexpressed in T cell leukemia bearing a t(X;14) translocation. Oncogene 9:3565–3570.
   PubMed Web of Science ®Google Scholar
• Thaete, C., D. Brett, P. Monaghan, S. Whitehouse, G. Rennie, E. Rayner, C. S. Cooper, and G. H. Goodwin. 1999. Functional domains of SYT and SYT-SSX synovial sarcoma translocation proteins and co-localization with the SNF protein BRM in the nucleus. Hum. Mol. Genet. 8:585–591.
   PubMedGoogle Scholar
• Tureci, O., U. Sahin, I. Schobert, M. Koslowski, H. Scmitt, H. J. Schild, F. Stenner, G. Seitz, H. G. Rammensee, and M. Pfreundschuh. 1996. The SSX-2 gene, which is involved in the t(X;18) translocation of synovial sarcomas, codes for the human tumor antigen HOM-MEL-40. Cancer Res. 56:4766–4772.
   PubMed Web of Science ®Google Scholar
• Vasseur, S., G. Vidal Mallo, F. Fiedler, H. Bodeker, E. Canepa, S. Moreno, and J. L. Iovanna. 1999. Cloning and expression of the human p8, a nuclear protein with mitogenic activity. Eur. J. Biochem. 59:670–675.
   Google Scholar
• Vasseur, S., A. Hoffmeister, A. Garcia-Montero, G. V. Mallo, R. Feil, S. Kuhbandner, J. C. Dagorn, and J. L. Iovanna. 2002. p8-deficient fibroblasts grow more rapidly and are more resistant to adriamycin-induced apoptosis. Oncogene 21:1685–1694.
   PubMedGoogle Scholar
• Xie, Y., B. Skytting, G. Nilsson, A. Gasbarri, K. Haslam, A. Bartolazzi, B. Brodin, N. Mandahl, and O. Larsson. 2002. SYT-SSX is critical for cyclin D1 expression in synovial sarcoma cells: a gain of function of the t(X;18)(p11.2;q11.2) translocation. Cancer Res. 62:3861–3867.
   PubMed Web of Science ®Google Scholar
• Xie, Y., B. Skytting, G. Nilsson, R. J. Grimer, C. D. Mangham, C. Fisher, J. Shipley, B. Bjerkehagen, O. Myklebost, and O. Larsson. 2002. The SYT-SSX1 fusion type of synovial sarcoma is associated with increased expression of cyclin A and D1. A link between t(X;18)(p11.2; q11.2) and the cell cycle machinery. Oncogene 21:5791–5796.
   PubMedGoogle Scholar
• Xie, Y., M. Tornkvist, Y. Aalto, G. Nilsson, L. Girnita, B. Nagy, S. Knuutila, and O. Larsson. 2003. Gene expression profile by blocking the SYT-SSX fusion gene in synovial sarcoma cells. Identification of XRCC4 as a putative SYT-SSX target gene. Oncogene 22:7628–7631.
   PubMedGoogle Scholar
• Yokoyama-Kobayashi, M., M. Saeki, S. Sekine, and K. Kato. 1997. Human cDNA encoding a novel TGF-beta superfamily protein highly expressed in placenta. J. Biochem. (Tokyo) 122:622–626.
   PubMed Web of Science ®Google Scholar
• Zhang, D., H. G. Yoon, and J. Wong. 2005. JMJD2A is a novel N-CoR-interacting protein and is involved in repression of the human transcription factor achaete scute-like homologue 2 (ASCL2/Hash2). Mol. Cell. Biol. 25:6404–6414.
   PubMed Web of Science ®Google Scholar